The neurological examination should always begin before the patient enters the doctor’s office. Movement disorders in particular lend themselves to a spot diagnosis. In today’s busy buzzing world, it seems wasteful not to make use of the various diagnostic clues that can be picked up readily while the patient is still in the waiting room. We present several illustrative examples, drawn from the literature and from our own experience. These are divided according to the different waiting room ‘stages’: the patient sitting in the waiting room, the response on being summoned to enter the consulting room—including rising from the chair, exchanging initial pleasantries and the way of walking. We also discuss the importance of paying attention to the patient’s behaviour, clothing, posture, breathing patterns, facial expression and major gait abnormalities.
- clinical neurology
- movement disorders
- waiting room
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors RA contributed with the review of the existing literature, provided video 1, conceptualised an early framework for the manuscript and drafted an early version of the paper. BvdW provided significant input to early versions of the manuscript, as well as review and critique of later versions. ALa and ALe provided significant input to both early and final versions of the manuscript, adding extensive examples drawn from their own personal experience. BB provided the idea for the manuscript, contributed to its early design, added several examples from his own personal experience, reviewed the final versions of the manuscript and provided the image for figure 1. He also takes responsibility for the integrity of the data and the accuracy of the data analysis.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Obtained.
Provenance and peer review Not commissioned. Externally peer reviewed by Paul Worth, Cambridge, UK.
Data sharing statement There are no unpublished data.
Read the full text or download the PDF:
Other content recommended for you
- Neuropathology and emerging biomarkers in corticobasal syndrome
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- Fifty years of progressive supranuclear palsy
- Sleep disturbance in movement disorders: insights, treatments and challenges
- Improving the diagnostic accuracy in parkinsonism: a three-pronged approach
- Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
- Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes
- Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy
- Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study
- Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy